It is named a focused therapy because it particularly targets the CD38 which might be overexpressed about the multiple myeloma cells. Daratumumab is from a class of medicines called CD38 monoclonal antibodies. Wegovy is also approved to cut back the potential risk of coronary heart attacks, strokes, and cardiovascular Dying https://ferdinandw592nuc5.worldblogged.com/profile